Link to this page
Biological and Environmental Research Ontology
| Id | http://purl.obolibrary.org/obo/NCIT_C151930
http://purl.obolibrary.org/obo/NCIT_C151930
|
|---|---|
| Preferred Name | Bushen-Jianpi Decoction |
| Definitions |
A traditional Chinese medicine (TCM) that is used for Yin deficiency of the liver, kidney and spleen, with potential immunomodulating and antineoplastic activities. Bushen-Jianpi decoction (BSJPD; BJD) consists of various herbs, including, but not limited to, Radix Codonopsis (Dang Shen), Fructus Lycii (the fruit of Chinese wolfberry), Rhizoma Atractylodis Macrocephalae (Baishu; Bai Zhu), Fructus Ligustri Lucidi, Cuscuta chinensis (Chinese dodder) seed, and Psoralea corylifolia Linn. As a TCM, Bushen-Jianpi is used as an antineoplastic agent as it is thought to invigorate the spleen and tonify the kidney, which presumably prevents or treats a variety of cancers. Upon administration of Bushen-Jianpi decoction, the ingredients in the decoction may affect signaling pathways involved in carcinogenesis and enhance the immune system by increasing the levels of numerous cytokines and a variety of immune cells, such as cytotoxic T-lymphocytes (CTLs), natural killer cells (NKs) and macrophages. It may also reduce the expression of various proteins involved in tumorigenesis.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A traditional Chinese medicine (TCM) that is used for Yin deficiency of the liver, kidney and spleen, with potential immunomodulating and antineoplastic activities. Bushen-Jianpi decoction (BSJPD; BJD) consists of various herbs, including, but not limited to, Radix Codonopsis (Dang Shen), Fructus Lycii (the fruit of Chinese wolfberry), Rhizoma Atractylodis Macrocephalae (Baishu; Bai Zhu), Fructus Ligustri Lucidi, Cuscuta chinensis (Chinese dodder) seed, and Psoralea corylifolia Linn. As a TCM, Bushen-Jianpi is used as an antineoplastic agent as it is thought to invigorate the spleen and tonify the kidney, which presumably prevents or treats a variety of cancers. Upon administration of Bushen-Jianpi decoction, the ingredients in the decoction may affect signaling pathways involved in carcinogenesis and enhance the immune system by increasing the levels of numerous cytokines and a variety of immune cells, such as cytotoxic T-lymphocytes (CTLs), natural killer cells (NKs) and macrophages. It may also reduce the expression of various proteins involved in tumorigenesis. |
|---|---|
| label | Bushen-Jianpi Decoction
|
| prefLabel | Bushen-Jianpi Decoction
|
| in_subset | |
| Preferred_Name | Bushen-Jianpi Decoction
|
| Is_Value_For_GDC_Property | |
| Maps_To | Bushen-Jianpi Decoction
|
| PDQ_Open_Trial_Search_ID | 793123
|
| prefixIRI | NCIT:C151930
|
| NCI_Drug_Dictionary_ID | 793123
|
| subClassOf | |
| code | C151930
|
| type | |
| PDQ_Closed_Trial_Search_ID | 793123
|
| Semantic_Type | Pharmacologic Substance
|
| NCI_META_CUI | CL553269
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |